Arnold & Porter

Arnold & Porter provides integrated and comprehensive counsel to global biopharma, biotech and medical device/diagnostic companies. It has a strong presence in regulatory and compliance areas relating to FDA legislative strategies and pharmaceutical, biologics and medical device companies, with experts such as Dan Kracov, Mahnu Davar and Allison Shuren. Howard Sklamberg’s expertise in global inspections and biomedical supply chains also contributes to the practice’s international reach. Demonstrating the practice’s tangible influence in government, Jeffrey Handwerker led the firm’s representation of PhRMA’s response to the Inflation Reduction Act as well as its constitutional challenges. The practice also leveraged its extensive expertise to advise life sciences businesses in novel challenges stemming from the development of Covid-19 vaccines, drugs, medical devices, and diagnostics. Additionally, the team’s activity branches to transactional matters, investigations and dispute resolutions, and IP and litigation strategies. Its successful representation of Sanofi and Regeneron in its case against Amgen is exemplary evidence of the latter. Key figures in the practice include Abeba Habtemariam, advising on regulatory, compliance, and legislative matters, and Kristin Hicks, who focuses on counseling and litigation. Giselle Joffre, Brian Dunphy and Todd Boudreau joined the life sciences and healthcare-focused Boston office in 2024, with Eva Temkin joining Washington DC’s regulatory practice.